Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia

European Journal of Haematology

Volumn 70, Issue 4, 2003, Pages 240-241

  Wahlin, Anders ^a,b   Golovleva, Irina ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic stem cell transplant; Chronic myeloid leukaemia; Essential thrombocythaemia; Hydroxyurea; Secondary leukaemia; Unrelated donor

Indexed keywords

HYDROXYUREA;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; BONE MARROW; BONE MARROW CELL; CASE REPORT; CELL ASSAY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GENDER; HEALTH STATUS; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; MEDICAL LITERATURE; MORPHOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TIME;

ANTINEOPLASTIC AGENTS; BONE MARROW EXAMINATION; HUMANS; HYDROXYUREA; INTERFERON-ALPHA; KARYOTYPING; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHILADELPHIA CHROMOSOME; REMISSION INDUCTION; THROMBOCYTHEMIA, HEMORRHAGIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037391357     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00043.x     Document Type: Article

References (6)

1. HARRISON CH. Current trends in essential thrombocythaemia. Br J Haematol 2002;117:796-808.
2. ANDERSSON P, RIDELL B, WADENVIK H, KUTTI J. Leukemic transformation of essential thrombocythaemia without previous cytoreductive treatment. Ann Hematol 2000;79:40-42.
3. FINAZZI G, RUGGERI M, RODEGHIERO F, BARBUI T. Second malignancies in patients with essential thrombocythaemia treated with busulfan and hydroxyurea: long-term follow-up of a randomized clinical trial. Br J Haematol 2000;110:577-583.
4. LIOZON E, TURLURE P. Leukemic risk in thrombocythaemia. Ann Med Intern (Paris) 1998;149:82-86.
5. AGUIAR RC. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leukemia Lymphoma 1998;29:17-26.
6. PEDERSEN-BJERGAARD J, BRONDUM-NIELSEN K, KARLE H, JOHANSSON B. Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia 1997;11:1571-1574.